FibroGen(FGEN) - 2023 Q1 - Earnings Call Transcript

Michael Tung - Vice President, Corporate Strategy & Investor Relations Enrique Conterno - Chief Executive Officer Juan Graham - Chief Financial Officer Mark Eisner - Chief Medical Officer John Hunter - Chief Scientific Officer Conference Call Participants Company Participants I would now like to hand the conference over to your speaker today, Michael Tung. Please go ahead. Thank you, Eleanor, and good afternoon everyone. I'm Michael Tung, Vice President of Corporate Strategy and Investor Relations at FibroG ...